T. Cundy et al., REVERSIBILITY OF HYPOGONADOTROPIC HYPOGONADISM ASSOCIATED WITH GENETIC HEMOCHROMATOSIS, Clinical endocrinology, 38(6), 1993, pp. 617-620
OBJECTIVE Recent reports have suggested that hypogonadotrophic hypogon
adism in men with genetic haemochromatosis can be reversed by aggressi
ve venesection therapy. We have studied prospectively men with this co
mplication of haemochromatosis in order to document the frequency and
completeness of recovery from hypogonadism. PATIENTS AND DESIGN Six me
n with symptomatic hypogonadotrophic hypogonadism and genetic haemochr
omatosis were studied before beginning venesection therapy and again a
fter depletion of body iron stores. MEASUREMENT Symptoms of hypogonadi
sm, serum gonadotrophins and serum total and free testosterone concent
rations. RESULTS Five men aged 47-66 showed no symptomatic improvement
and no change in serum gonadotrophin or testosterone concentrations.
The symptoms of one man, aged 33, resolved completely after venesectio
n and this was accompanied by increases in serum LH and FSH. Serum tot
al and free testosterone concentrations increased fourfold, but remain
ed subnormal. CONCLUSION Only one partial recovery from hypogonadotrop
hic hypogonadism was seen and this was in the youngest subject. In rev
iewing the other documented cases of reversal it would appear that the
age at diagnosis is critical and there are no proven cases of reversa
l of hypogonadotrophic hypogonadism in men over the age of 40 at the s
tart of venesection therapy.